Typicality: | 0.406 |
Saliency: | 0.366 |
by experimenting with different materials | 5 | manner |
on pyrabactin derivatives | 2 | other |
on neural degeneration | 2 | other |
colleague → continue → their research | 9 |
colleague → plan to continue → their research | 6 |
negative | neutral | positive |
0.017 | 0.685 | 0.298 |
Raw frequency | 15 |
Normalized frequency | 0.366 |
Modifier score | 0.500 |
Perplexity | 55.327 |